Human Trials of COVAXIN, ZyCOV-D Mark the 'Beginning of the End' of COVID-19 Pandemic, a Scientist Says An Indian scientist said that the Drug Controller General of India's nod to conduct human trials for Indian Covid-19 vaccine candidates Covaxin and ZyCov-D mark the beginning of the end of the coronavirus pandemic. by CJ Robles